AP1401A
Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic- depressive bipolar disorder.
Abstract
Anticonvulsant derivatives useful in treating Manic-depressive disorder are disclosed.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
Every citation, both waysCites: the store holds 1 of 2
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US4513006A | Cites | United States of America | Search report |
| DELUCCHI et al.: Vol. 56, No. 8, 1989, pp 756-761 | Non-patent | – | Search report |
55 members in 25 offices
Priority claims11
| Document | Office | Kind | Date |
|---|---|---|---|
| 2085096 | United States of America | P | |
| 2085096 | United States of America | P | |
| 88100897 | United States of America | A | |
| 88100897 | United States of America | A | |
| 9710949 | United States of America | W | |
| 9710949 | United States of America | W | |
| 60020580 | – | – | – |
| PCTUS9701949 | – | – | – |
| US19960020850P | – | – | – |
| US19970881008 | – | – | – |
| WO1997US10949 | – | – | – |
Members55
| Document | Office | Kind | |
|---|---|---|---|
| WO9747135A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3219797A | Australia | A | |
| CA2258895A1 | Canada | A1 | |
| WO9800123A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3409697A | Australia | A | |
| US5753693A | United States of America | A | |
| NO986051D0 | Norway | D0 | |
| ZA975773B | South Africa | B | |
| AP9801427A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| NO986051L | Norway | L | |
| WO9935846A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2103499A | Australia | A | |
| CN1224350A | China | A | |
| EP0932398A1 | European Patent Office (EPO) | A1 | |
| CZ427798A3 | Czechia | A3 | |
| US5945988A | United States of America | A | |
| IL127714A0 | Israel | A0 | |
| IL127714D0 | Israel | D0 | |
| US5977964A | United States of America | A | |
| SK180498A3 | Slovakia | A3 | |
| KR20000022233A | Republic of Korea | A | |
| NZ333565A | New Zealand | A | |
| BR9712783A | Brazil | A | |
| EP1046293A1 | European Patent Office (EPO) | A1 | |
| TW418588B | Taiwan Province of China | B | |
| CN1292977A | China | A | |
| HU0003381A2 | Hungary | A2 | |
| HUP0003381A2 | Hungary | A2 | |
| AU739363B2 | Australia | B2 | |
| HU0003381A3 | Hungary | A3 | |
| HUP0003381A3 | Hungary | A3 | |
| EP1046293A4 | European Patent Office (EPO) | A4 | |
| JP2002503896A | Japan | A | |
| JP2002515875A | Japan | A | |
| RU2185824C2 | Russian Federation | C2 | |
| UA59363C2 | Ukraine | C2 | |
| IL127714A | Israel | A | |
| NO317641B1 | Norway | B1 | |
| AP1401AThis record | African Regional Intellectual Property Organization (ARIPO) | A | |
| EP1046293B1 | European Patent Office (EPO) | B1 | |
| DE69928374D1 | Germany | D1 | |
| CA2258895C | Canada | C | |
| EP0932398B1 | European Patent Office (EPO) | B1 | |
| DE69928374T2 | Germany | T2 | |
| AT330593T | Austria | T | |
| ATE330593T1 | Austria | T1 | |
| DE69736183D1 | Germany | D1 | |
| DK0932398T3 | Denmark | T3 | |
| PT932398E | Portugal | E | |
| CZ297342B6 | Czechia | B6 | |
| ES2267144T3 | Spain | T3 | |
| DE69736183T2 | Germany | T2 | |
| CN1331356C | China | C | |
| JP2007243980A | Japan | A | |
| JP4629066B2 | Japan | B2 |
Numbers
- Publication
- AP 1401
- Publication, DOCDB
- 1401
- Publication, EPODOC
- AP1401
- Application
- 1998001427
- Application, DOCDB
- 9801427
- Application, EPODOC
- AP19980001427
Titles
- English
- Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic- depressive bipolar disorder.
Classification
- CPC, 8
- H04N21/44222
- A61K31/18
- A61K31/255
- A61K31/35
- A61P25/00
- A61P25/08
- A61P25/18
- A61P25/24
- IPC, 10
- C07D309 06
- A61K31 18
- A61K31 255
- A61K31 35
- A61K31 351
- A61K31 357
- A61P25 00
- A61P25 18
- A61P25 24
- C07D493 04